Cost-Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Monotherapy in Elderly Type 2 Diabetes Patients in Thailand

ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s113559